Recent Updates
Recently added Catalysts
MESO Neutral Sentiment

appendix3y-cha Appendix 3Y Change of Director's Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not

Key Takeaway: Mesoblast Limited has submitted a Change of Director's Interest Notice to the ASX regarding Jane C. Bell's recent acquisition of ordinary shares. On April 12, 2024, Bell acquired 233,918 ordinary shares, increasing her indirect holdings to 543,441 shares. This acquisition reflects a transaction valued at approximately $199,999.89. The report follows ASX rules for disclosing changes in director interests.
Price reaction · baseline $4.69 (2024-04-16 close) · hit after-hours · clean, no other MESO news in the window
day 0 close
+6.8%
day 1
+9%
day 3 · peak
+17.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Director Jane C. Bell has increased her holdings in Mesoblast Limited.
  • Acquisition of shares suggests confidence in the company's future.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+91%
120-day peak, hindsight
Typical move
31.6%
average across 4 past catalysts
Lead asset
Prochymal
Phase 2 · Pulmonary Disease, Chronic Obstructive

Full Press Release Details

Appendix 3Y Change of Director's Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Mesoblast Limited ABN 68 109 431 870 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Jane C. Bell Date of last notice 15 January 2024 Part 1 - Change of director's relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Jane Catherine Bell and Geoffrey Arthur Bell as trustees for the family self-managed superannuation fund Date of change 12 April 2024 No. of securities held prior to change 526,729 options, held directly 309,523 ordinary shares, held indirectly Class Ordinary shares Number acquired 233,918 ordinary shares Number disposed Not applicable Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $199,999.89 (A$0.855 per share) No. of securities held after change 526,729 options, held directly 543,441 ordinary shares, held indirectly
Appendix 3Y Change of Director's Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back On market share purchase Part 2 - Change of director's interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part. Detail of contract Not applicable Nature of interest Not applicable Name of registered holder (if issued securities) Not applicable Date of change Not applicable No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Not applicable Interest acquired Not applicable Interest disposed Not applicable Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Not applicable Interest after change Not applicable Part 3 - +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? Not applicable If prior written clearance was provided, on what date was this provided? Not applicable

Frequently Asked Questions

What is Appendix 3Y?

Appendix 3Y is a notice for reporting changes in a director's interest in securities.

Who is the director mentioned in the notice?

The director named in the notice is Jane C. Bell.

What was the date of the reported change?

The date of the reported change was 12 April 2024.

How many shares did Jane C. Bell acquire?

Jane C. Bell acquired 233,918 ordinary shares.

Was prior written clearance required for trading?

No, prior written clearance was not required during the closed period.

Last updated: Apr 17, 2024